全球体外诊断市场规模、份额、趋势和成长分析报告（2026-2034）

体外诊断市场预计将从 2025 年的 931.1 亿美元成长到 2034 年的 1,310.4 亿美元，2026 年至 2034 年的复合年增长率为 3.87%。

由于慢性病发病率上升以及对早期、精准诊断解决方案的需求日益增长，体外诊断（IVD）市场预计将迎来显着增长。体外诊断检测（IVD）利用血液、尿液和组织等检体，在疾病的检测、后续观察和管理中发挥至关重要的作用。随着医疗机构越来越重视个人化和预防性医疗，对先进体外诊断技术的需求预计将会增加。分子诊断、就地检验和自动化领域的技术创新正在提高诊断过程的准确性和效率，从而进一步推动市场成长。

体外诊断（IVD）领域的科技进步也在塑造着该市场的未来。快速检测方法的开发以及人工智慧（AI）和机器学习在数据分析中的应用，正在彻底改变诊断方式。这些创新使医疗专业人员能够及时获得检测结果，从而加快决策速度，并改善患者预后。此外，随着患者寻求便捷的诊断解决方案，居家检测和远端医疗的趋势也可能对体外诊断市场产生正面影响。

此外，新兴经济体医疗基础设施的扩张预计将对体外诊断市场产生积极影响。亚太和拉丁美洲等地区医疗服务可近性的提高以及对高品质诊断服务需求的成长将推动体外诊断产品的消费。专注于开发创新且经济高效的诊断解决方案，并针对特定区域需求量身定制的公司，将更有利于获得市场份额。随着体外诊断市场的不断发展，技术进步、监管变化和消费者偏好转变之间的相互作用预计将创造一个充满活力、成长机会和创新空间的市场环境。

目录

第一章 引言

第二章执行摘要

第三章 市场变数、趋势与框架

• 市场谱系展望
• 绘製渗透率和成长前景图
• 价值链分析
• 法律规范
  • 标准与合规性
  • 监管影响分析
• 市场动态
  • 市场驱动因素
  • 市场限制
  • 市场机会
  • 市场问题
• 波特五力分析
• PESTLE分析

4. 全球体外诊断市场（依产品类型划分）

• 市场分析、洞察与预测
• 装置
• 试剂
• 软体
• 服务

5. 全球体外诊断市场（依技术划分）

• 市场分析、洞察与预测
• 免疫检测
• 临床化学
• 分子诊断
• 血液学
• 微生物学
• 凝血
• 其他的

6. 全球体外诊断市场（依应用划分）

• 市场分析、洞察与预测
• 感染疾病
• 肿瘤学
• 心臟病学
• 肾臟病学
• 自体免疫疾病
• 其他的

7. 全球体外诊断市场（依最终用户划分）

• 市场分析、洞察与预测
• 医院
• 诊断检查室
• 学术研究机构
• 其他的

8. 全球体外诊断市场（依地区划分）

• 区域分析
• 北美市场分析、洞察与预测
  • 我们
  • 加拿大
  • 墨西哥
• 欧洲市场分析、洞察与预测
  • 英国
  • 法国
  • 德国
  • 义大利
  • 俄罗斯
  • 其他欧洲国家
• 亚太市场分析、洞察与预测
  • 印度
  • 日本
  • 韩国
  • 澳洲
  • 东南亚
  • 其他亚太国家
• 拉丁美洲市场分析、洞察与预测
  • 巴西
  • 阿根廷
  • 秘鲁
  • 智利
  • 其他拉丁美洲国家
• 中东和非洲市场分析、洞察与预测
  • 沙乌地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中东和非洲国家

第九章 竞争情势

• 最新趋势
• 公司分类
• 供应链和销售管道合作伙伴（根据现有资讯）
• 市场占有率和市场定位分析（基于现有资讯）
• 供应商格局（基于现有资讯）
• 策略规划

第十章：公司简介

• 主要公司的市占率分析
• 公司简介
  • Roche Diagnostics
  • Abbott Laboratories
  • Siemens Healthineers
  • Danaher Corporation
  • Thermo Fisher Scientific
  • Becton, Dickinson And Company（BD）
  • Bio-Rad Laboratories
  • BioMAfA（C）Rieux
  • Qiagen
  • Hologic
  • Sysmex Corporation
  • Ortho Clinical Diagnostics
  • Agilent Technologies
  • Illumina

The In Vitro Diagnostics Market size is expected to reach USD 131.04 Billion in 2034 from USD 93.11 Billion (2025) growing at a CAGR of 3.87% during 2026-2034.

The in vitro diagnostics (IVD) market is poised for substantial growth, driven by the increasing prevalence of chronic diseases and the rising demand for early and accurate diagnostic solutions. IVD tests, which are performed on samples such as blood, urine, and tissue, play a critical role in disease detection, monitoring, and management. As healthcare providers increasingly prioritize personalized medicine and preventive care, the demand for advanced IVD technologies is expected to rise. Innovations in molecular diagnostics, point-of-care testing, and automation are enhancing the accuracy and efficiency of diagnostic processes, further propelling market growth.

Technological advancements in IVD are also shaping the future of this market. The development of rapid testing methods and the integration of artificial intelligence and machine learning in data analysis are revolutionizing the way diagnostics are performed. These innovations enable healthcare professionals to obtain timely results, facilitating quicker decision-making and improved patient outcomes. Additionally, the growing trend towards home-based testing and telemedicine is likely to influence the IVD market positively, as patients seek convenient and accessible diagnostic solutions.

Moreover, the expansion of healthcare infrastructure in emerging economies is expected to positively impact the in vitro diagnostics market. As access to healthcare improves and the demand for quality diagnostic services increases in regions such as Asia-Pacific and Latin America, the consumption of IVD products will rise. Companies that focus on developing innovative and cost-effective diagnostic solutions tailored to specific regional needs will be well-positioned to capture market share. As the IVD market evolves, the interplay of technological advancements, regulatory changes, and shifting consumer preferences will create a dynamic environment ripe with opportunities for growth and innovation.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Product Type

• Instruments
• Reagents
• Software
• Services

By Technology

• Immunoassay
• Clinical Chemistry
• Molecular Diagnostics
• Hematology
• Microbiology
• Coagulation
• Others

By Application

• Infectious Diseases
• Oncology
• Cardiology
• Nephrology
• Autoimmune Diseases
• Others

By End-User

• Hospitals
• Diagnostic Laboratories
• Academic and Research Institutes
• Others

COMPANIES PROFILED

• Roche Diagnostics, Abbott Laboratories, Siemens Healthineers, Danaher Corporation, Thermo Fisher Scientific, Becton, Dickinson and Company BD, BioRad Laboratories, bioMrieux, Qiagen, Hologic, Sysmex Corporation, Ortho Clinical Diagnostics, Agilent Technologies, Illumina

We can customise the report as per your requriements

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL IN VITRO DIAGNOSTICS MARKET: BY PRODUCT TYPE 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Product Type
• 4.2. Instruments Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Reagents Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Software Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.5. Services Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL IN VITRO DIAGNOSTICS MARKET: BY TECHNOLOGY 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Technology
• 5.2. Immunoassay Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Clinical Chemistry Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Molecular Diagnostics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.5. Hematology Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.6. Microbiology Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.7. Coagulation Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.8. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL IN VITRO DIAGNOSTICS MARKET: BY APPLICATION 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast Application
• 6.2. Infectious Diseases Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Oncology Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Cardiology Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.5. Nephrology Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.6. Autoimmune Diseases Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.7. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL IN VITRO DIAGNOSTICS MARKET: BY END-USER 2022-2034 (USD MN)

• 7.1. Market Analysis, Insights and Forecast End-user
• 7.2. Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.3. Diagnostic Laboratories Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.4. Academic and Research Institutes Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.5. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL IN VITRO DIAGNOSTICS MARKET: BY REGION 2022-2034(USD MN)

• 8.1. Regional Outlook
• 8.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.2.1 By Product Type
  • 8.2.2 By Technology
  • 8.2.3 By Application
  • 8.2.4 By End-user
  • 8.2.5 United States
  • 8.2.6 Canada
  • 8.2.7 Mexico
• 8.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.3.1 By Product Type
  • 8.3.2 By Technology
  • 8.3.3 By Application
  • 8.3.4 By End-user
  • 8.3.5 United Kingdom
  • 8.3.6 France
  • 8.3.7 Germany
  • 8.3.8 Italy
  • 8.3.9 Russia
  • 8.3.10 Rest Of Europe
• 8.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.4.1 By Product Type
  • 8.4.2 By Technology
  • 8.4.3 By Application
  • 8.4.4 By End-user
  • 8.4.5 India
  • 8.4.6 Japan
  • 8.4.7 South Korea
  • 8.4.8 Australia
  • 8.4.9 South East Asia
  • 8.4.10 Rest Of Asia Pacific
• 8.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.5.1 By Product Type
  • 8.5.2 By Technology
  • 8.5.3 By Application
  • 8.5.4 By End-user
  • 8.5.5 Brazil
  • 8.5.6 Argentina
  • 8.5.7 Peru
  • 8.5.8 Chile
  • 8.5.9 South East Asia
  • 8.5.10 Rest of Latin America
• 8.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.6.1 By Product Type
  • 8.6.2 By Technology
  • 8.6.3 By Application
  • 8.6.4 By End-user
  • 8.6.5 Saudi Arabia
  • 8.6.6 UAE
  • 8.6.7 Israel
  • 8.6.8 South Africa
  • 8.6.9 Rest of the Middle East And Africa

Chapter 9. COMPETITIVE LANDSCAPE

• 9.1. Recent Developments
• 9.2. Company Categorization
• 9.3. Supply Chain & Channel Partners (based on availability)
• 9.4. Market Share & Positioning Analysis (based on availability)
• 9.5. Vendor Landscape (based on availability)
• 9.6. Strategy Mapping

Chapter 10. COMPANY PROFILES OF GLOBAL IN VITRO DIAGNOSTICS INDUSTRY

• 10.1. Top Companies Market Share Analysis
• 10.2. Company Profiles
  • 10.2.1 Roche Diagnostics
  • 10.2.2 Abbott Laboratories
  • 10.2.3 Siemens Healthineers
  • 10.2.4 Danaher Corporation
  • 10.2.5 Thermo Fisher Scientific
  • 10.2.6 Becton, Dickinson And Company (BD)
  • 10.2.7 Bio-Rad Laboratories
  • 10.2.8 BioMAfA(C)Rieux
  • 10.2.9 Qiagen
  • 10.2.10 Hologic
  • 10.2.11 Sysmex Corporation
  • 10.2.12 Ortho Clinical Diagnostics
  • 10.2.13 Agilent Technologies
  • 10.2.14 Illumina